RecruitingAdenocarcinoma of the ColonAdenocarcinoma of the RectumStage I Colorectal Cancer
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this research study is to determine whether testing of stool for a panel of markers will enable us to detect polyps and cancer compared to standard testing.
Sponsor: Case Comprehensive Cancer Center
You may qualify if…
- ✓ Diagnosis of stage I, II or III adenocarcinoma of the colon or rectum
- ✓ Receipt of preoperative colonoscopy
- ✓ Receipt of bowel resection; use of adjuvant chemotherapy or radiation therapy as clinically indicated
You may not qualify if…
- ✕ Stage IV colorectal cancer
- ✕ Surgical treatment with subtotal colectomy or total proctocolectomy
- ✕ Diagnosis of inflammatory bowel disease (ulcerative colitis or Crohn's disease)
- ✕ Diagnosis of polyposis syndrome including Lynch syndrome or familial polyposis
- ✕ Presence of advanced adenomas (1 cm or larger, villous features and/or high grade dysplasia) that were not removed at the preoperative colonoscopy or contained in the resection specimen.
- ✕ Inability to provide informed consent
- ✕ Inability to understand spoken and written English
- ✕ Medical comorbidities that would be contraindications to sedation or that would preclude any benefit of routine surveillance post-resection. These would be at the discretion of the participant's providers.
Where it's recruiting
Ohio
Cleveland
Source: ClinicalTrials.gov · NCT04624555 · last updated 2026-04-09